Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pentron is a dental consumables and restorative materials company focused on products used by dentists for impression taking, bonding, cements, composites, post-and-core procedures, and temporary restorations. The company traces its roots to 1967 and markets a portfolio that includes brands such as FibreKleer, FibreKor, Build-It, Correct Plus, Simile, Bond-1, Breeze, and TempSpan. Pentron operates as a healthcare company within restorative dentistry rather than a therapeutics developer, so it does not have a biotech-style clinical pipeline. Pentron was acquired by Kerr in 2010 and today functions as part of Kerr Dental, which is an operating company within Envista. Its business is centered on commercially available dental materials, manufacturing, technical support, and distribution through dealer networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pentron.